Literature DB >> 10074117

Mapping the genetic determinants of pathogenicity and plaque phenotype in swine vesicular disease virus.

T Kanno1, D Mackay, T Inoue, G Wilsden, M Yamakawa, R Yamazoe, S Yamaguchi, J Shirai, P Kitching, Y Murakami.   

Abstract

A series of recombinant viruses were constructed using infectious cDNA clones of the virulent J1'73 (large plaque phenotype) and the avirulent H/3'76 (small plaque phenotype) strains of swine vesicular disease virus to identify the genetic determinants of pathogenicity and plaque phenotype. Both traits could be mapped to the region between nucleotides (nt) 2233 and 3368 corresponding to the C terminus of VP3, the whole of VP1, and the N terminus of 2A. In this region, there are eight nucleotide differences leading to amino acid changes between the J1'73 and the H/3'76 strains. Site-directed mutagenesis of individual nucleotides from the virulent to the avirulent genotype and vice versa indicated that A at nt 2832, encoding glycine at VP1-132, and G at nt 3355, encoding arginine at 2APRO-20, correlated with a large-plaque phenotype and virulence in pigs, irrespective of the origin of the remainder of the genome. Of these two sites, 2APRO-20 appeared to be the dominant determinant for the large-plaque phenotype but further studies are required to elucidate their relative importance for virulence in pigs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10074117      PMCID: PMC104027     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A.

Authors:  S J Hambidge; P Sarnow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

2.  A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating.

Authors:  J M Tatem; C Weeks-Levy; A Georgiu; S J DiMichele; E J Gorgacz; V R Racaniello; F R Cano; S J Mento
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  A foot and mouth disease syndrome in pigs caused by an enterovirus.

Authors:  L Nardelli; E Lodetti; G L Gualandi; R Burrows; D Goodridge; F Brown; B Cartwright
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

4.  Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype.

Authors:  M Caggana; P Chan; A Ramsingh
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  The complete nucleotide sequence of a pathogenic swine vesicular disease virus isolated in Japan (J1'73) and phylogenetic analysis.

Authors:  T Inoue; S Yamaguchi; T Kanno; S Sugita; T Saeki
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

6.  Studies on dicistronic polioviruses implicate viral proteinase 2Apro in RNA replication.

Authors:  A Molla; A V Paul; M Schmid; S K Jang; E Wimmer
Journal:  Virology       Date:  1993-10       Impact factor: 3.616

7.  Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.

Authors:  H H Lu; C F Yang; A D Murdin; M H Klein; J J Harber; O M Kew; E Wimmer
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Intratypic genome variability of the coxsackievirus B1 2A protease region.

Authors:  J Zoll; J Galama; W Melchers
Journal:  J Gen Virol       Date:  1994-03       Impact factor: 3.891

9.  A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.

Authors:  H Zhang; N W Blake; X Ouyang; Y A Pandolfino; P Morgan-Capner; L C Archard
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  Role for poliovirus protease 2A in cap independent translation.

Authors:  A J Macadam; G Ferguson; T Fleming; D M Stone; J W Almond; P D Minor
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  11 in total

1.  Expression and immunological analysis of capsid protein precursor of swine vesicular disease virus HK/70.

Authors:  Hong Tian; Jing-yan Wu; You-jun Shang; Shuang-hui Ying; Hai-xue Zheng; Xiang-tao Liu
Journal:  Virol Sin       Date:  2010-06-06       Impact factor: 4.327

2.  Importance of arginine 20 of the swine vesicular disease virus 2A protease for activity and virulence.

Authors:  Toru Inoue; Soren Alexandersen; Angela T Clark; Ciara Murphy; Melvyn Quan; Scott M Reid; Yoshihiro Sakoda; Helen L Johns; Graham J Belsham
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Molecular determinants of virulence, cell tropism, and pathogenic phenotype of infectious bursal disease virus.

Authors:  M Brandt; K Yao; M Liu; R A Heckert; V N Vakharia
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  An attenuating mutation in the 2A protease of swine vesicular disease virus, a picornavirus, regulates cap- and internal ribosome entry site-dependent protein synthesis.

Authors:  Y Sakoda; N Ross-Smith; T Inoue; G J Belsham
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Structure of swine vesicular disease virus: mapping of changes occurring during adaptation of human coxsackie B5 virus to infect swine.

Authors:  Núria Verdaguer; Miguel A Jimenez-Clavero; Ignacio Fita; Victoria Ley
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Crystal structure of Swine vesicular disease virus and implications for host adaptation.

Authors:  Elizabeth E Fry; Nick J Knowles; John W I Newman; Ginette Wilsden; Zihe Rao; Andrew M Q King; David I Stuart
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  Mapping genetic determinants of the cell-culture growth phenotype of enterovirus 71.

Authors:  Patchara Phuektes; Beng Hooi Chua; Sharon Sanders; Emily J Bek; Chee Choy Kok; Peter C McMinn
Journal:  J Gen Virol       Date:  2011-02-23       Impact factor: 3.891

8.  Genome sequence analysis of in vitro and in vivo phenotypes of Bunyamwera and Ngari virus isolates from northern Kenya.

Authors:  Collins Odhiambo; Marietjie Venter; Konongoi Limbaso; Robert Swanepoel; Rosemary Sang
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

9.  Characterization of Plaque Variants and the Involvement of Quasi-Species in a Population of EV-A71.

Authors:  Madiiha Bibi Mandary; Malihe Masomian; Seng-Kai Ong; Chit Laa Poh
Journal:  Viruses       Date:  2020-06-17       Impact factor: 5.048

10.  Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.

Authors:  Yao Wang; Julie K Pfeiffer
Journal:  MBio       Date:  2016-03-29       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.